Abstract
Platelet transfusion is the main mode of management of thrombocytopenia. However, some studies link frequent and high-threshold platelet transfusions with an incremental increase of mortality rate.
Aim This study aims to assess the association between the frequency and the threshold of platelet transfusions, with the mortality rate among preterm neonates.
Methods A retrospective cohort study design was used. This study was conducted at maternity and children’s hospitals in Al-Ahasa, Saudi Arabia. The sample size includes 154 preterm neonates, included in the study by the use of the convenience sampling technique.
Result There is a significant relationship found between the gestational age and the birth weight of the preterm neonates with the survival rates among both groups. In contrast, there is no significant relationship found between transfusion frequency, transfusion threshold, and the survival rates of the group which received platelet transfusion.
Implications for Practice and Research The current study found that mortality is mainly associated with lower gestational ages, and not platelet transfusions. More studies are needed to fill the remaining gaps of knowledge, and to optimise platelet transfusion practices among preterm neonates.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
There is no funding for this research
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The approval for this study was obtained from ethical committee in the Standing Committee for Research Ethics on Living Creatures (SCRELC) Imam Abdulrahman bin Faisal University, Saudi Arabia. Then, an approval was taken from the Research Ethics Committee (REC) of Maternity and Children Hospital (MCH) at Alhasa city in Kingdome of Saudi Arabia.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The data is available with the researcher as well as on the medical records at the selected setting.
